About Scilabs

A multidimensional firm committed to rethinking the standard approach to traditional pharmaceutical applications.

Read More

Research & Development

With patent pending technology, our team of experts is leading the change in pharmaceutical research and development.

Read More

News

GlaxoSmithKline
A candidate Ebola vaccine could be given to healthy volunteers in the UK, The Gambia and Mali as early as September, as part of a series of safety trials of potential vaccines aimed at preventing the disease that has killed more than 1,400 people in the current outbreak in west [...]
Fri, Aug 29, 2014 9:00:00 AM, Continue reading at the source